StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
RPG Life Sciences Limited
NSE:RPGLIFE.NS
Sector
Location
Market Cap
USD 510.05 M
Share Price
USD 29.19
Avg Daily Volume
31,033
Change (1 day)
0.31%
Change (1 year)
23.94%
Change (YTD)
14.39%
RPG Life Sciences Limited EBIT Margin for the year ending March 31, 2025: 21.15%
RPG Life Sciences Limited EBIT Margin is 21.15% for the year ending March 31, 2025, a 2.41% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
RPG Life Sciences Limited EBIT Margin for the year ending March 31, 2024 was 20.66%, a 14.10% change year over year.
-
RPG Life Sciences Limited EBIT Margin for the year ending March 31, 2023 was 18.10%, a 6.11% change year over year.
-
RPG Life Sciences Limited EBIT Margin for the year ending March 31, 2022 was 17.06%, a 18.13% change year over year.
-
RPG Life Sciences Limited EBIT Margin for the year ending March 31, 2021 was 14.44%, a 35.97% change year over year.
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
Johnson & Johnson
USD 169.56
JNJ
+0.46
0.27%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
McKesson Corporation
USD 710.19
MCK
-3.81
-0.53%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Elevance Health Inc.
USD 280.43
ELV
-16.17
-5.45%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Lonza Group AG
USD 711.54
LONN.SW
-7.05
-0.98%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
Johnson & Johnson
USD 169.56
JNJ
+0.46
0.27%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
McKesson Corporation
USD 710.19
MCK
-3.81
-0.53%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Elevance Health Inc.
USD 280.43
ELV
-16.17
-5.45%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Lonza Group AG
USD 711.54
LONN.SW
-7.05
-0.98%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%